News

As a not-for-profit organisation, the Allergen Bureau relies on membership and services revenue to fund our work, and we are delighted to have the support of Reckitt in 2023. Reckitt* exists to protect, heal and nurture in the relentless pursuit…

Allergen detection method considerations and data gaps must be addressed in the shift toward quantitative, risk-based allergen management strategies, says Dr Melanie Downs of Food Allergy Research and Resource Program (FARRP) in the Department of Food Science and Technology at…

Early lab trials using a new research-based treatment for the prevention of peanut allergy are showing the potential for it to be an effective preventative for peanut-specific allergic responses. The new treatment, referred to as ‘Covalent heterobivalent inhibitor’ (cHBI), works…

People with coeliac disease have been found to have a higher chance of having heart disease compared to those without coeliac disease. The findings come from a study using data from the UK Biobank, a large database of health information,…

The prevalence of allergic diseases in the Middle East Region is said to be rapidly increasing, while food allergy knowledge in the population is lacking. Recent studies have delved deeper into prevalence and knowledge of food allergies in Saudi Arabia.…

To ensure that VITAL Online remains up to date with best practice technology the Allergen Bureau will shortly be introducing multifactor authentication to your VITAL Online log in. Just like your banking system, by using recognised Authenticators like Google Authenticator…